Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001144204-15-026505)

Filing Details

Accession Number:: 0001144204-15-026505
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-04-30 15:55:06
Reporting Period:: 2012-04-16

Filing Date:: 2015-04-30
Accepted Time:: 2015-04-30 15:55:06
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1072379	Northwest Biotherapeutics Inc	NWBO	Pharmaceutical Preparations (2834)	943306718

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1204048	J Jerry Jasinowski	C/O Northwest Biotherapeutics, Inc. 4800 Montgomery Lane, Suite 800 Bethesda MD 20814		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.001	Acquisiton	2012-10-18	35,715	$5.60	35,715	No	4	P	Direct
Common Stock, Par Value $0.001	Acquisiton	2012-10-10	43,602	$4.80	79,317	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrants	Acquisiton	2012-03-27	31,250	$6.40	31,250	$6.40
Common Stock	Warrants	Acquisiton	2012-08-08	17,857	$5.60	17,858	$5.60
Common Stock	Warrants	Acquisiton	2012-10-10	9,810	$6.40	9,810	$6.40

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
31,250	2012-03-27	2017-03-27	No	4	X	Direct
49,107	2012-08-08	2017-08-08	No	4	X	Direct
58,917	2012-10-10	2017-10-10	No	4	X	Direct

Footnotes

Does not include warrants to purchase shares of common stock which are currently exercisable.